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Abstract
Allergic airways inflammation in asthma is characterized by an airway epithe-
lial gene signature composed of POSTN, CLCA1, and SERPINB2. This Th2
gene signature is proposed as a tool to classify patients with asthma into Th2-
high and Th2-low phenotypes. However, many asthmatics smoke and the
effects of cigarette smoke exposure on the epithelial Th2 gene signature are
largely unknown. Therefore, we investigated the combined effect of IL-13 and
whole cigarette smoke (CS) on the Th2 gene signature and the mucin-related
genes MUC5AC and SPDEF in air–liquid interface differentiated human bron-
chial (ALI-PBEC) and tracheal epithelial cells (ALI-PTEC). Cultures were
exposed to IL-13 for 14 days followed by 5 days of IL-13 with CS exposure.
Alternatively, cultures were exposed once daily to CS for 14 days, followed by
5 days CS with IL-13. POSTN, SERPINB2, and CLCA1 expression were mea-
sured 24 h after the last exposure to CS and IL-13. In both models POSTN,
SERPINB2, and CLCA1 expression were increased by IL-13. CS markedly
affected the IL-13-induced Th2 gene signature as indicated by a reduced
POSTN, CLCA1, and MUC5AC expression in both models. In contrast, IL-13-
induced SERPINB2 expression remained unaffected by CS, whereas SPDEF
expression was additively increased. Importantly, cessation of CS exposure
failed to restore IL-13-induced POSTN and CLCA1 expression. We show for
the first time that CS differentially affects the IL-13-induced gene signature
for Th2-high asthma. These findings provide novel insights into the interac-
tion between Th2 inflammation and cigarette smoke that is important for
asthma pathogenesis and biomarker-guided therapy in asthma.
Introduction
Asthma is a syndrome characterized by airway hyperre-
sponsiveness, chronic inflammation, and mucus hyper-
secretion. Historically asthma, and particularly allergic
asthma, has been considered to be mainly driven by a T
helper 2 (Th2)-mediated immune response. However, it
is now well recognized that asthma is a heterogeneous
disease with different pathophysiological pathways under-
lying airway inflammation (Wenzel 2012). Molecular phe-
notyping of diseased airway tissue has the potential to
unravel the multiple phenotypes of asthma. Furthermore,
it allows the identification of biomarkers associated with
specific disease patterns to select patients for personalized
targeted therapies.
Approximately 50% of asthmatic patients have Th2-
mediated disease (Woodruff et al. 2009; Wenzel 2012). A
Th2-high subtype of asthma has been described and is
associated with increased bronchial epithelial expression
of periostin (POSTN), serpin B2 (SERPINB2), and chlo-
ride channel regulator 1 (CLCA1), and predicts a benefi-
cial therapeutic response to corticosteroids (Woodruff
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et al. 2007, 2009). Recently various clinical trials have
shown the potential of inhibitors of Th2 inflammation,
including monoclonal antibodies against interleukin (IL)-
13, to modulate clinical outcomes in asthma (van Buul
and Taube 2015). IL-13 is produced by Th2 cells and has
been shown to have marked effects on airway epithelial
cells (Whittaker et al. 2002; Woodruff et al. 2007). IL-13
is an important mediator for the induction of goblet cell
metaplasia in Th2-mediated asthma and is a central regu-
lator in the epithelial expression of POSTN, SERPINB2,
and CLCA1 (Woodruff et al. 2007). Periostin, the protein
encoded by the POSTN gene, is of particular interest as a
biomarker, as it is detectable in the circulation and may
be useful as a blood biomarker for IL-13-activated bron-
chial epithelial cells. Indeed, there is evidence suggesting
that circulating periostin levels may help in the identifica-
tion of asthma patients that benefit from anti-IL-13 treat-
ment (Corren et al. 2011; Noonan et al. 2013; Brightling
et al. 2015).
Asthma has a genetic predisposition, but is it recog-
nized that environmental factors are very important in
the pathogenesis. An important environmental factor
influencing asthma pathogenesis is cigarette smoking.
Approximately 20–35% of the world population smokes,
with surprisingly similar smoking rates reported in asth-
matic patients (Cerveri et al. 2012; To et al. 2012; Thom-
son et al. 2013). Cigarette smoking has been shown to
worsen asthma symptoms, reduce responsiveness to corti-
costeroid treatment, accelerate lung function decline, and
increase exacerbation rates (Polosa and Thomson 2013).
Additionally, smoking is strongly predictive for the devel-
opment of new onset asthma in atopic adults (Polosa
et al. 2008). As a history of current or former smoking is
present in approximately 20–30% of the asthmatic
population (Cerveri et al. 2012; Thomson et al. 2013),
cigarette smoking could be considered as one of the most
important environmental factors influencing asthma
pathogenesis.
We have previously shown that the IL-13-induced
epithelial Th2 gene signature can be differentially affected
by azithromycin treatment, suggesting that IL-13 induces
its gene expression pattern through various pathways
(Mertens et al. 2016). Furthermore, a suppressive effect of
cigarette smoke on POSTN and SERPINB2 gene expres-
sion has previously been suggested based on a study
focusing on the presence of a Th2 gene signature in
patients with chronic obstructive pulmonary disease
(COPD) (Christenson et al. 2015). Surprisingly little is
known about the effect of cigarette smoking on IL-13-
activated airway epithelial cells and the IL-13-induced
gene expression pattern described for Th2-high asthma.
Therefore, we have investigated, for the first time, the
combined effect of whole cigarette smoke exposure and
IL-13 on primary human airway epithelial cells cultured
at the air–liquid interface, thus providing novel insights
into the interaction between Th2 inflammation and cigar-
ette smoke that is relevant for asthma pathogenesis and
biomarker-guided therapy in asthma.
Material and Methods
Cell culture
Human primary bronchial epithelial cells (PBEC) were
isolated from macroscopically normal bronchial tissues
obtained from lung cancer patients undergoing lobectomy
at the Leiden University Medical Center (Leiden, The
Netherlands). Primary tracheal epithelial cells were iso-
lated from residual tracheal and main stem bronchial tis-
sue from lung transplant donors postmortem at the
University Medical Center Groningen (Groningen, the
Netherlands). Use of lung tissue that became available for
research within the framework of patient care was in line
with the “Human Tissue and Medical Research: Code of
conduct for responsible use” (2011) (www.federa.org) that
describes the no-objection system for coded anonymous
further use of such tissue. Therefore, individual written or
verbal consent is not applicable. Details on isolation of
PBEC (Mertens et al. 2016) and PTEC (Kistemaker et al.
2015) were described previously. During 14 days of differ-
entiation, cell culture medium was replaced every 2 days.
Cultured PBEC and PTEC were used for generation of
mucociliary differentiated cultures by differentiation at
the air–liquid interface (ALI) as described previously
(Mertens et al. 2016). Briefly, PBEC and PTEC at passage
2 were cultured submerged on semipermeable transwell
inserts with 0.4 lm pore size (Corning Costar, Cam-
bridge, MA) that were coated with a mixture of bovine
serum albumin, collagen type 1, and fibronectin. Once
full confluence was reached, apical medium was removed
and PBEC or PTEC were used for subsequent experimen-
tal exposures.
Experimental design
Two experimental models were used to investigate the
effects of whole cigarette smoke exposure on the IL-13-
induced expression pattern (Fig. 1). In exposure Model
A, ALI-PBEC or ALI-PTEC were grown to confluence,
and cultured for 14 days at the ALI in the presence of 1
or 2.5 ng/mL IL-13 which was added in the basolateral
compartment of the transwell insert, followed by an addi-
tional 5 days once daily whole cigarette smoke or air
exposure in the presence or absence of continued treat-
ment with 1 or 2.5 ng/mL recombinant human IL-13
(Peprotech, Rocky Hill, CT) which was added in the
2017 | Vol. 5 | Iss. 13 | e13347
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basolateral compartment of the transwell insert. In Model
B, ALI-PBEC or ALI-PTEC were grown to confluence,
and next cultured at the ALI and exposed once daily to
whole cigarette smoke or air for 14 days, followed by an
additional 5 days once daily whole cigarette smoke or air
exposure in the presence or absence of continued treat-
ment with 10 ng/ml IL-13 that was added to the basolat-
eral compartment of the transwell insert. For both
models, ALI-PBEC or ALI-PTEC were rinsed apically with
200 lL PBS, 4 h prior to whole cigarette smoke or air
exposure. During 14 days of exposure, cell culture med-
ium was replaced every two days. During the last 5 days
of exposure, medium was refreshed daily, directly after
whole cigarette smoke or air exposure. Twenty-four hours
after the last whole cigarette smoke or air exposure, cells
were lysed for RNA or protein extraction, and basal med-
ium was collected and stored at 20°C until further use.
Whole cigarette smoke exposure
ALI-PBEC or ALI-PTEC were exposed to cigarette smoke
generated from 3R4F reference cigarettes (University of
Kentucky, Lexington, KY) in a whole cigarette smoke
exposure model adapted from Beisswenger et al. (2004)
as described previously (Amatngalim et al. 2015). In brief,
ALI cultures were placed into modified hypoxic chambers
(Billups Rothenberg, Del Mar, CA), localized inside an
incubator at 37°C and 5% CO2. Whole cigarette smoke
derived from one cigarette, or air as negative control, was
permeated inside the respective exposure chamber using a
continuous flow of 1 l/min for a period of 4–5 min. After
exposure, residual smoke inside the exposure chamber
was removed by flushing the chambers with air derived
from the incubator for a period of 10 min. After smoke
or air exposure, cell culture medium was refreshed and
cells were incubated at 37°C and 5% CO2.
RNA isolation, RT, and qPCR
Total RNA was extracted using the Maxwell 16 LEV sim-
plyRNA Tissue Kit (Promega, Leiden, The Netherlands)
and quantified using the Nanodrop ND-1000 UV-visible
spectrophotometer (Nanodrop Technologies, Wilmington,
DE). For cDNA synthesis, 1 lg of total RNA was reverse
transcribed using oligo(dT) primers and Moloney murine
leukemia virus (M-MLV) polymerase (Promega) at 37°C.
Primer sequences are listed in Table 1. RPL13A and
ATP5B were used as reference genes following selection
by the Genorm method (Vandesompele et al. 2002). All
quantitative PCRs (qPCRs) were carried out in triplicate
on a CFX-384 real-time PCR detection system (Bio-Rad
Laboratories, Veenendaal, The Netherlands) with the use
of SYBR green (Bio-Rad). Bio-Rad CFX manager 3.1 soft-
ware (Bio-Rad) was used to calculate arbitrary gene
expression by using the standard curve method.
Periostin and mucin 5AC ELISA
Periostin protein expression was measured in medium
collected from the basolateral compartment of the tran-
swell 24 h after the last whole cigarette smoke or air
exposure. Periostin ELISA was performed according to
the manufacturer’s instruction (R&D Systems Europe
Ltd., Abingdon, United Kingdom). For Mucin 5AC pro-
tein expression, cells were lysed in RIPA buffer 24 h after
the last whole cigarette smoke or air exposure according
to the manufacturer’s instruction (Thermo Fisher Scien-
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Figure 1. Exposure setup to investigate the effect of whole cigarette smoke exposure on the IL-13-induced expression pattern in human
bronchial and tracheal epithelial cells. ALI, air–liquid interface; IL-13, interleukin-13; PBEC, primary bronchial epithelial cells; PTEC, primary
tracheal epithelial cells.
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bicarbonate coating buffer without azide and incubated in
a NUNC maxisorp ELISA plate (Thermo Fisher Scientific)
at 37°C until dry. Plates were washed and nonspecific
binding sites were blocked with PBS/2% (w/v) BSA
(Sigma-Aldrich Chemie BV, Zwijndrecht, The Nether-
lands) for 2 h at room temperature, followed by 2 h
incubation with mouse anti-MUC5AC (1:200; 45M1;
Thermo Fisher Scientific) in PBS/0.05% Tween-20 (v/v)
(Sigma-Aldrich) at room temperature. Next, plates were
washed with PBS/0.05% Tween-20 and incubated for 1 h
with goat anti-mouse HRP (1:2000, Dako Denmark A/S,
Glostrup, Denmark) at room temperature. Plates were
developed using tetramethylbenzidine-hydrogen peroxi-
dase solution and the reaction was stopped with 2.5 mol/
L H2SO4. Absorbance was measured at 450 nm using a
Microplate reader (iMark; Bio-Rad Laboratories, Her-
cules, CA) and Microplate Manager Software (version 6.3,
Bio-Rad).
SDS-PAGE and western blot
Protein RIPA lysates were diluted (1:1 [v/v]) in sodium
dodecyl sulfate (SDS) sample buffer containing 4% (w/v)
SDS (Sigma-Aldrich), 20% (v/v) glycerol (Merck), 0.8%
(w/v) DL-dithiothreitol (Sigma-Aldrich), 0.5 mol/L Tris
pH 6.8 and 0.003% (w/v) bromophenol blue (Sigma-
Aldrich), heated for 5 min at 100°C, and applied on a 4–
15% SDS-PAGE gel (Mini-PROTEAN TGX, Bio-Rad).
Next, proteins were blotted on a Trans-Blot Turbo Mini
PDVF membrane using the Trans-Blot Turbo Transfer
System (Bio-Rad). Nonspecific binding sites were blocked
in Tris-buffered saline (TBS)/0.05% (v/v) Tween-20 con-
taining 5% (w/v) skimmed milk. Membranes were probed
with rabbit-anti-CLCA1 (1:1000; EPR12254-88; Abcam,
Cambridge, United Kingdom), rabbit-anti-SERPINB2
(1:1000; ab47742; Abcam), rabbit-anti-POSTN (1:1000,
ab14041, Abcam), or GAPDH (1:1000; 14C10; Cell
Signaling Technologies, Leiden, The Netherlands) in 5%
(w/v) BSA TBS/0.05% (v/v) Tween-20 overnight at 4°C.
Next, membranes were incubated with anti-rabbit IgG
HRP-linked antibody (1:10,000, Cell Signaling Technolo-
gies) in blocking buffer for 1 h and binding was revealed
using enhanced chemiluminescence substrate (Thermo
Fisher Scientific).
Statistical analysis
Graphs were made and statistical analysis was performed
in GraphPad PRISM 6.0 (GraphPad Software Inc., La
Jolla, CA). Differences were explored by one-way ANOVA
with Dunnett’s test. Data are shown as means  SEM of
cultures derived from several donors and differences were
considered significant at P < 0.05.
Results
An established IL-13-induced gene
expression pattern is differentially affected
by whole cigarette smoke exposure
First, we investigated the effect of whole cigarette smoke
(CS) exposure on an established IL-13-induced Th2 gene
expression pattern in ALI-PBEC. To this end, ALI-PBEC
were differentiated for 14 days in the presence of IL-13 to
establish this Th2 gene signature, followed by 5 days expo-
sure to CS in the presence or absence of IL-13 (Fig. 1,
Model A). IL-13-differentiated ALI-PBEC showed indeed
significantly increased expression of the Th2 signature
genes POSTN, SERPINB2, and CLCA1, in addition to the
goblet cell metaplasia-related genes MUC5AC and SAM,
pointed domain containing ETS transcription factor
(SPDEF) (Fig. 2A). IL-13-differentiated ALI-PBEC exposed
to CS in the presence of IL-13 had significantly reduced
POSTN expression compared to the IL-13-differentiated
ALI-PBEC exposed to air in the presence of IL-13. In con-
trast, MUC5AC and SERPINB2 expression remained unaf-
fected, whereas SPDEF expression was additively increased
in CS-exposed IL-13-differentiated ALI-PBEC compared to
air exposure (Fig. 2A). Cessation of IL-13 exposure during
the last 5 days reduced IL-13-induced gene expression back
to baseline expression levels, suggesting that the effect of
IL-13 does not persist (Fig. 2A). Cigarette smoke exposure
has previously been shown alter methylation patterns in
airway epithelial cells (Beane et al. 2007). As mucin 5AC
and periostin are both important biomarker proteins, we
validated our gene expression findings for MUC5AC and
Table 1. Primer sequences with gene names and NCBI gene ID




POSTN F: GAC CGT GTG CTT ACA CAA ATT G 10631
R: AAG TGA CCG TCT CTT CCA AGG
SERPINB2 F: TCC TGG GTC AAG ACT CAA ACC 5055
R: CAT CCT GGT ATC CCC ATC TAC AG
CLCA1 F: ATG GCT ATG AAG GCA TTG TCG 1179
R: TGG CAC ATT GGG GTC GAT TG
MUC5AC F: CCT TCG ACG GAC AGA GCT AC 4586
R: TCT CGG TGA CAA CAC GAA AG
SPDEF F: ATG AAA GAG CGG ACT TCA CCT 25803
R: CTG GTC GAG GCA CAG TAG TG
RPL13A F: AAG GTG GTG GTC GTA CGC TGT G 23521
R: CGG GAA GGG TTG GTG TTC ATC C
ATP5B F: TCA CCC AGG CTG GTT CAG A 506
R: AGT GGC CAG GGT AGG CTG AT
2017 | Vol. 5 | Iss. 13 | e13347
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POSTN using ELISA (Fig. 2B). Mucin 5AC protein expres-
sion appeared to be lowered upon IL-13 exposure cessation;
however, 5 days seems insufficient time to return protein
levels to baseline expression levels. Additionally, periostin
protein could only be detected in ALI-PBEC that were con-
tinuously exposed to IL-13 without the presence of CS
(Fig. 2B).
To investigate whether the effect of CS on IL-13-
induced POSTN expression resulted from CS-induced
DNA methylation effects, we daily treated CS-exposed IL-
13-differentiated ALI-PBEC with the demethylating
compound 5-azacytidine (5 or 25 lmol/L) during the last
5 days of CS exposure. However, 5-azacytidine treatment
during CS exposure was unable to restore POSTN expres-
sion levels (Fig. 3).
Whole cigarette smoke exposure
differentially affects IL-13-induced
responsiveness
Our results showed a noticeably differential effect of CS


































































































































































































































Figure 2. Effect of whole cigarette smoke exposure on IL-13-induced gene expression in ALI-PBEC. ALI-PBEC were differentiated with IL-13
(1 ng/mL) for 14 days followed by an additional 5 days with IL-13 (1 ng/mL) in the presence of air or CS exposure. MUC5AC, POSTN,
SERPINB2, SPDEF, and CLCA1 gene expression (A) were assessed by qRT-PCR; periostin and mucin 5AC proteins (B) were assessed by ELISA.
Results are expressed as mean  SEM fold change compared to IL-13-exposed ALI-PBEC exposed to air (indicated by a horizontal dashed line)
with n = 4 independent donors. *P < 0.05. ALI, air–liquid interface; CS, whole cigarette smoke exposure; IL-13, interleukin-13; PBEC, primary
bronchial epithelial cells.
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pattern in ALI-PBEC. Next, we investigated whether
chronic CS exposure in ALI-PBEC affected the ability of
IL-13 to promote the expression of these genes. To this
end, we differentiated ALI-PBEC with daily CS exposure
or air as a control for 14 days, followed by another
5 days of daily CS (or air) exposure in the absence or
presence of IL-13 (10 ng/mL, added in the basal cham-
ber) as depicted in Figure 1, Model B. Pilot results indi-
cated that short-term IL-13 exposure of ALI-PBEC
differentiated in the presence of CS exposure induced
STAT6 phosphorylation, an important downstream
mediator of IL-13-induced changes, to the same extent as
control differentiated ALI-PBEC, suggesting that CS-dif-
ferentiated ALI-PBEC are still able to respond to IL-13
(results not shown). Control ALI-PBEC exposed for
5 days to IL-13 displayed an increased expression of the
Th2-signature genes POSTN, SERPINB2, and CLCA1, in
addition to an increase in the goblet cell metaplasia-
related genes MUC5AC and SPDEF (Fig. 4A). In contrast,
CS-differentiated ALI-PBEC exposed to IL-13 had
significantly reduced POSTN and CLCA1 expression and
a trend for reduced MUC5AC expression (P = 0.094),
whereas SERPINB2 and SPDEF expression remained unaf-
fected compared to IL-13-exposed control ALI-PBEC
(Fig. 4A). These data indicate that upon CS exposure, IL-
13 is unable to promote the Th2-signature gene expres-
sion to a similar extend as it does in air-exposed controls.
We next investigated whether CS-induced reduction of
POSTN, CLCA1, and MUC5AC expression would return
to IL-13-stimulated control levels upon cessation of CS
exposure. After 14 days of daily CS exposure, CS-differen-
tiated ALI-PBEC were exposed for 5 additional days to
air in the presence or absence of IL-13. Results showed
that upon CS cessation, both POSTN and CLCA1 gene
expression remained diminished in the presence of IL-13;
however, MUC5AC expression was fully restored to the
level of IL-13-incubated air-exposed control ALI-PBEC
(Fig. 4A). The findings for mucin 5AC and periostin were
confirmed on protein level using ELISA (Fig. 4B). Overall,














































































































































































Figure 3. Whole cigarette smoke exposure does not affect the IL-13-induced Th2 gene signature through promoter methylation. ALI-PBEC
were differentiated with IL-13 (1 ng/mL) for 14 days followed by an additional 5 days with IL-13 (1 ng/mL) in the presence of air or whole
cigarette smoke exposure with or without 5-azacytidine. MUC5AC, POSTN, SERPINB2, SPDEF, and CLCA1 gene expression (A) were assessed by
qRT-PCR; POSTN and MUC5AC proteins (B) were assessed by ELISA. Results are expressed as mean  SEM fold change compared to IL-13-
exposed ALI-PBEC exposed to air (indicated by a horizontal dashed line) with n = 4 independent donors. *P < 0.05. ALI, air–liquid interface; 5-
AZA, 5-azacytidine; CS, whole cigarette smoke exposure; IL-13, interleukin-13; ND, not detected; PBEC, primary bronchial epithelial cells.
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significantly affects IL-13-induced gene expression pat-
terns in ALI-PBEC.
Regional differences in the lung do not
affect responses to cigarette smoke and
IL-13
Primary tracheal epithelial cells (PTEC) are more easily
accessible for biomarker studies due to their anatomic
location compared to bronchial epithelial cells.
Furthermore, tracheal epithelial cells have previously been
shown to have a similar biological response to CS expo-
sure compared to the small airway epithelium (Turetz
et al. 2009). To investigate whether ALI-PTEC show simi-
lar responses to ALI-PBEC following combined IL-13 and
CS exposure, we exposed ALI-PTEC according to Models
A and B (Fig. 1). ALI-PTEC responded similar compared
to ALI-PBEC, with a few exceptions (Figs. 5, 6). In addi-
tion to reduced POSTN expression by CS-exposed IL-13-




























































































































































































































Figure 4. Effect of IL-13 on ALI-PBEC differentiated in the presence of air or whole cigarette smoke exposure. ALI-PBEC were exposed to once
daily air or CS exposure during differentiation for 14 days, followed by an additional 5 days with IL-13 (10 ng/mL) in the presence of air or CS
exposure. MUC5AC, POSTN, SERPINB2, SPDEF, and CLCA1 gene expression (A) were assessed by qRT-PCR; periostin and mucin 5AC proteins
(B) were assessed by ELISA. Results are expressed as mean  SEM fold change compared to IL-13-exposed ALI-PBEC exposed to air (indicated
by a horizontal dashed line) with n = 4 independent donors. *P < 0.05. ALI, air–liquid interface; CS, whole cigarette smoke exposure; IL-13,
interleukin-13; PBEC, primary bronchial epithelial cells.
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reduced in ALI-PTEC compared to air-exposed controls
(Figs. 5A, 6A), suggesting a slightly stronger disturbance
of the Th2 gene signature by CS in ALI-PTEC compared
to the ALI-PBEC. Gene expression data for mucin 5AC
and periostin were confirmed at the protein level in ALI-
PTEC using ELISA (Fig. 5B, 6B). Taken together, our
results suggest that CS differentially affects the IL-13-
induced expression in ALI-PTEC. Moreover, ALI-PTEC
can be used as an alternative model for ALI-PBEC to
study the effects of IL-13 and CS exposure with regard to
the IL-13-induced Th2 gene signature.
Discussion
The present results show that chronic whole cigarette
smoke (CS) exposure differentially affects the IL-13-
induced gene expression pattern in primary bronchial and







































































































































































































































Figure 5. Effect of whole cigarette smoke exposure on IL-13-induced gene expression in ALI-PTEC. ALI-PTEC were differentiated with IL-13
(1 ng/mL) for 14 days followed by an additional 5 days with IL-13 (1 ng/mL) in the presence of air or CS. MUC5AC, POSTN, SERPINB2, SPDEF,
and CLCA1 gene expression (A) were assessed by qRT-PCR; periostin and mucin 5AC proteins (B) were assessed by ELISA. Results are expressed
as mean  SEM fold change compared to IL-13-exposed ALI-PTEC exposed to air (indicated by a horizontal dashed line) with n = 4
independent donors. *P < 0.05. ALI, air–liquid interface; CS, whole cigarette smoke exposure; IL-13, interleukin-13; PTEC, primary tracheal
epithelial cells.
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Although IL-13-induced POSTN expression was lowered
upon subsequent CS exposure, MUC5AC, CLCA1, and
SERPINB2 expression remained unaffected and SPDEF
expression was further increased. Conversely, IL-13-
responsiveness of primary airway epithelial cells was also
severely affected by CS. Differentiation of airway epithelial
cells in the presence of CS followed by IL-13 exposure
resulted in reduced expression of POSTN, CLCA1, and
MUC5AC, whereas SERPINB2 and SPDEF expression
remained unaffected. Cessation of CS exposure in the
presence of IL-13 was insufficient to restore POSTN and
CLCA1 expression, while MUC5AC expression was fully
restored. Together, these data suggest that CS affects, even
upon cessation, the Th2 gene signature that has been sug-
gested to distinguish Th2-high and Th2-low patients.
The clinical effects of smoking in asthmatic patients
have been well described. However, little is known about
the effect of cigarette smoking on the molecular pheno-
type that has been suggested for Th2-high asthma. Several







































































































































































































































Figure 6. Effect of IL-13 on ALI-PTEC differentiated in the presence of whole cigarette smoke exposure. ALI-PTEC were exposed to daily air or
CS exposure during differentiation for 14 days, followed by an additional 5 days with IL-13 (10 ng/mL) in the presence of air or CS. MUC5AC,
POSTN, SERPINB2, SPDEF, and CLCA1 gene expression (A) were assessed by qRT-PCR; periostin and mucin 5AC proteins (B) were assessed by
ELISA. Results are expressed as mean  SEM fold change compared to IL-13-exposed ALI-PTEC exposed to air (indicated by a horizontal dashed
line) with n = 4 independent donors. *P < 0.05. ALI, air–liquid interface; CS, whole cigarette smoke exposure; IL, interleukin; ND, not detected;
PTEC, primary tracheal epithelial cells.
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reported a suppressive effect of cigarette smoke on Th2-
mediated inflammation, including goblet cell metaplasia
(Melgert et al. 2004; Robbins et al. 2005; Trimble et al.
2009; Hizume et al. 2012; Tilp et al. 2016). A suppressive
effect of cigarette smoke on POSTN and SERPINB2
expression could be expected based on observations on
the presence of a Th2 gene signature in a subset of smok-
ing and nonsmoking COPD patients (Christenson et al.
2015). Among the genes that comprise the Th2 gene sig-
nature, periostin is of particular interest as it can be
detected in serum, thus serving as an easy accessible bio-
marker to distinguish Th2-high from Th2-low asthma
patients. Furthermore, high serum periostin levels have
been shown to predict therapy response to anti-IL-13
treatment (Corren et al. 2011; Hanania et al. 2013;
Brightling et al. 2015). In our exposure models, we
noticed a marked decrease in periostin mRNA and pro-
tein levels upon CS exposure. These data are also in line
with a recently published study showing that serum peri-
ostin levels are lower in smoking asthmatics compared to
nonsmoking controls (Thomson et al. 2015). Indeed, the
current study shows the effect of smoking at a cellular
level, in part, explaining the results observed in the afore-
mentioned patient study. In addition, the present study
also shows that CS exposure cessation failed to restore
IL-13-induced POSTN expression levels, indicating persis-
tence of the effect of CS exposure on IL-13 responsive-
ness. Several studies have indicated a persistent effect on
gene expression profiles in former smokers even several
years after smoke cessation, suggesting the involvement of
smoking-induced epigenetic mechanisms (Beane et al.
2007; Chari et al. 2007; Zhang et al. 2008). A long-lasting
effect after smoking cessation in asthmatics on corticos-
teroid responsiveness has also been suggested by the
observation of an attenuated response to corticosteroid
treatment in former smokers with asthma (Chaudhuri
et al. 2006). To investigate whether DNA methylation was
involved in the observed effects of CS exposure on perios-
tin expression, we used the demethylating agent 5-aza
during CS exposure. However, treatment with 5-aza failed
to prevent the CS-induced modulation of POSTN and
CLCA1 expression, suggesting that DNA methylation is
not pivotal in the persistence of decreased expression after
CS exposure. However, we cannot formally exclude
that possibility that another demethylating agent would
have prevented this CS-induced modulation of gene
expression.
Both CS and IL-13 have been linked to goblet cell
metaplasia in airway epithelial cells in vitro and in vivo.
In Th2-mediated asthma, goblet cell metaplasia and asso-
ciated MUC5AC overexpression are mainly attributed to
the presence of IL-13. IL-13 induces SPDEF and CLCA1
expression, both essential genes involved in the
development of IL-13-induced MUC5AC expression
(Zhen et al. 2007; Yu et al. 2010; Alevy et al. 2012). Gob-
let cell metaplasia is increased in smokers, and several
studies using cigarette smoke have shown the induction
of MUC5AC (Wright et al. 1983; Chari et al. 2007; Cor-
tijo et al. 2011; Iwashita et al. 2012; Wu et al. 2012;
Schamberger et al. 2015). Most studies have focused on
the effects of cigarette smoke extract rather than whole
cigarette smoke to induce goblet cell metaplasia. We
observed an increase in SPDEF expression, a gene previ-
ously shown to be important in the development of gob-
let cell metaplasia (Park et al. 2007; Chen et al. 2009). In
contrast, the present data showed no increase in
MUC5AC expression in airway epithelial cells exposed to
CS. Together, these data suggest that smoking induces a
first “hit” for the development of goblet cell metaplasia in
smokers, but that an extra stimulus from, for example,
underlying tissue inflammation may be required for the
development of mucus hypersecretion following goblet
cell metaplasia. In our experimental setup, exposure to
CS reduced IL-13-induced epithelial markers of goblet cell
metaplasia. This reduced MUC5AC and CLCA1 expres-
sion in CS-differentiated airway epithelial cells exposed to
IL-13 may be explained by the presence of heme oxyge-
nase 1. Cigarette smoke has previously been shown to
induce heme oxygenase 1 expression in our whole cigar-
ette exposure model setup (Zarcone et al. 2016). Heme
oxygenase 1 has been shown to inhibit IL-13-induced-
MUC5AC expression and more recently, this process was
shown to be associated with reduced CLCA1 expression
in human bronchial epithelial cells (Almolki et al. 2008;
Mishina et al. 2015).
The relevance of our findings is further enhanced by
the use of primary epithelial cells derived from multiple
donors and from multiple anatomical locations instead of
the use of cell lines. In addition, we used cells that were
differentiated at the air–liquid interface to allow mucocil-
iary differentiation, instead of cell lines that do not differ-
entiate and display other abnormalities. Finally, we used
freshly prepared mainstream whole cigarette smoke con-
taining both the gaseous and particulate components
instead of the widely used aqueous extracts of CS.
Although quantification of the exposure to whole smoke
is difficult, in our view it does provide a more accurate
representation of cigarette smoke exposure (gaseous and
particulate constituents) compared to aqueous extracts.
Bronchial epithelial cells were derived from macroscopi-
cally normal resected tissue obtained during surgery for
lung cancer from patients that were largely (ex)smokers.
Furthermore, epithelial cells from asthmatics were not
available to further evaluate the effect of CS on a clini-
cally established Th2 signature. We considered the possi-
bility that cigarette smoke also likely modulates epithelial
2017 | Vol. 5 | Iss. 13 | e13347
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gene expression induced by cytokines other than IL-13
that are known to be increased in asthma, such as IL-17.
However, we focused on IL-13 because it has been well
described that the gene expression pattern observed in
airway epithelial cells from patients with allergic asthma
is well reflected by IL-13 treatment of cultured primary
airway epithelial cells (Woodruff et al. 2007, 2009).
In conclusion, our results indicate that CS differen-
tially affects the IL-13-induced expression profile includ-
ing the recently described epithelial 3 gene signature for
Th2-high asthma. The observation that CS markedly
reduces IL-13-induced CLCA1 and POSTN expression,
which does not recover after CS cessation, is an impor-
tant finding for biomarker-guided therapy in asthma
since especially periostin is considered as an emerging
biomarker for Th2 inflammation. Possibly, periostin may
not be a good biomarker for Th2 inflammation in asth-
matics that smoke. The observation that CS is able to
reduce MUC5AC expression but not SPDEF expression
remains to be further elucidated. Collectively, our results
provide novel insight in the interaction between Th2
inflammation and cigarette smoke that is relevant for
asthma pathogenesis and biomarker-guided therapy in
asthma.
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